Basic Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Feb 7, 2022; 28(5): 547-569
Published online Feb 7, 2022. doi: 10.3748/wjg.v28.i5.547
Table 2 Clinicopathological relevance of connective tissue growth factor mRNA expression in colorectal cancer patients as determined by quantitative real-time polymerase chain reaction
Characteristics
Normal expression (n = 14)
Overexpression (n = 57)
Odds ratio (95%CI)
P value
Chi2
Age
< 502 (9.52)19 (90.48)Referent
≥ 5012 (24.00)38 (76.00)3.0 (0.6-29.9)0.161.95
Gender
Male4 (10.53)34 (89.47)Referent
Female10 (30.30)23 (69.70)3.6 (0.9-17.8)0.037a4.36
Dwelling
Rural11 (23.40)36 (76.60)Referent
Urban3 (12.50)21 (87.50)0.5 (0.1-2.1)0.271.19
Social class
Low7 (31.82)15 (68.18)Referent
Middle and high7 (14.29)42 (85.71)0.4 (0.09-1.4)0.082.94
Family history
Yes3 (15.00)17 (85.00)Referent
No11 (21.57)40 (78.43)1.5 (0.3-9.7)0.530.39
Smoking status
Yes4 (10.00)36 (90.00)Referent
No10 (32.26)21 (67.74)4.3 (1.04-20.68)0.019a5.46
Lifestyle
Active8 (25.81)23 (74.19)Referent
Sedentary6 (15.00)34 (85.00)0.5 (0.1-1.1)0.251.28
Salt tea intake
Yes13 (20.00)52 (80.00)Referent
No1 (16.67)5 (83.33)0.8 (0.02-8.1)0.8440.03
Red meat consumption
Yes13 (22.03)46 (77.97)Referent
No1 (8.33)11 (91.67)0.3 (0.01-2.6)0.371.22
Sundried vegetables
Yes9 (18.75)39 (81.25)Referent
No5 (21.74)18 (78.26)1.2 (0.2-4.7)0.7670.08
Source of drinking water
Tap water (R)12 (26.09)34 (73.91)Referent
Tap water (L)1 (14.29)6 (85.71)0.5 (0.01-5.3)
Others11 (5.56)17 (94.44)0.4 (0.04-2.4)0.541.21
Pickles
Yes8 (19.51)33 (80.49)Referent
No6 (20.00)24 (80.00)1.03 (0.3-3.9)1.0000.002
Pesticide exposure
Yes7 (21.21)26 (78.79)Referent
No7 (18.42)31 (81.58)0.84 (0.219-3.21)0.80.07
Junk food consumption
Yes0 (0)5 (100)Referent
No14 (21.21)52 (91.23)0 (0-3.08)0.251.32
Site of tumor
Colon7 (19.44)29 (80.56)Referent
Rectum6 (30.00)14 (70.00)1.8 (0.4-7.45)
Rectosigmoid1 (6.67)14 (93.33)0.3 (0.01-2.7)0.232.91
Tumor differentiation
Well8 (44.44)10 (55.56)
Moderate5 (10.87)41 (89.13)Referent
Poor1 (14.29)6 (85.71)0.15 (0.03-0.7)0.009a9.35
Invasion depth
T15 (62.50)3 (37.50)
T27 (31.82)15 (68.18)Referent
T32 (6.45)29 (93.55)0.3 (0.03-2.0)0.001a17.21
T40 (0)10 (100)
T1 + T212 (40.00)18 (60.00)
T3 + T42 (4.88)39 (95.12)0.08 (0.008-0.4)0.000a13.5
TNM staging
I11 (44.00)14 (56.00)Referent
II2 (8.00)23 (92.00)0.1 (0.01-0.6)0.002a14.5
III1 (5.56)17 (94.44)0.07 (0.01-0.7)
IV0 (0)3 (100.00)0.040a4.21
I + II13 (26.00)37 (74.00)
III + IV1 (4.76)20 (95.24)0.1 (0.01-1.1)
Tumor grade
18 (44.44)10 (55.56)
25 (10.87)41 (89.13)Referent
31 (14.29)6 (85.71)0.1 (0.03-0.7)0.009a9.35
DUKE stage
A2 (2.82)3 (4.23)
B11 (15.49)33 (46.48)Referent
C1 (1.41)21 (29.58)0.5 (0.05-6.8)0.042a5.20
Node status
013 (25.49)38 (74.51)Referent
1 and 21 (5.00)19 (95.00)0.1 (0.003-1.2)0.041a3.81
LVI
Present8 (14.81)46 (85.19)Referent
Absent6 (35.29)11 (64.71)3.1 (0.7-12.7)0.0643.42
PNI
Present0 (0.00)15 (100)Referent
Absent14 (25.00)42 (75.00)0 (0-1.08)0.031a4.67
TALNR
Present11 (17.74)51 (82.26)Referent
Absent3 (33.33)6 (66.67)2.3 (0.32-12.8)0.2721.20
Necrosis seen
Yes17 (94.44)1 (5.56)Referent
No40 (75.47)13 (24.53)2.7 (0.5-27.7)0.0803.10
Recurrence
Yes0 (0)12 (100)Referent
No14 (23.73)45 (76.27)0 (0-1.08)0.0603.55
Vital status
Alive13 (19.70)53 (80.30)Referent
Death1 (20.00)4 (80.00)1.4 (0.02-1.9)0.850.07